153 related articles for article (PubMed ID: 32692980)
21. A Case of the Co-Existence of Subcorneal Pustular Dermatosis and Pyoderma Gangrenosum and a Review of the Literature.
Ferrillo M; Villani A; Fabbrocini G; Mascolo M; Megna M; Costa C; Napolitano M
Open Access Maced J Med Sci; 2018 Jul; 6(7):1271-1274. PubMed ID: 30087735
[TBL] [Abstract][Full Text] [Related]
22. Pyoderma gangrenosum, acne, and suppurative hidradenitis syndrome in end-stage renal disease successfully treated with adalimumab.
De Wet J; Jordaan HF; Kannenberg SM; Tod B; Glanzmann B; Visser WI
Dermatol Online J; 2017 Dec; 23(12):. PubMed ID: 29447652
[TBL] [Abstract][Full Text] [Related]
23. Subcorneal pustular dermatosis treated successfully with adalimumab.
de Encarnação Roque Diamantino F; Dias Coelho JM; Macedo Ferreira AM; Fidalgo AI
Eur J Dermatol; 2010; 20(4):512-4. PubMed ID: 20395190
[No Abstract] [Full Text] [Related]
24. Finally, recurrent pyoderma gangrenosum treated with Adalimumab: case report and review of the literature.
Campanati A; Brisigotti V; Ganzetti G; Molinelli E; Giuliodori K; Consales V; Racchini S; Bendia E; Offidani A
J Eur Acad Dermatol Venereol; 2015 Jun; 29(6):1245-7. PubMed ID: 25200926
[No Abstract] [Full Text] [Related]
25. Autoinflammatory pustular neutrophilic diseases.
Naik HB; Cowen EW
Dermatol Clin; 2013 Jul; 31(3):405-25. PubMed ID: 23827244
[TBL] [Abstract][Full Text] [Related]
26. Bullous pyoderma gangrenosum as the presenting sign of fatal acute myelogenous leukemia.
Fox LP; Geyer AS; Husain S; Grossman ME
Leuk Lymphoma; 2006 Jan; 47(1):147-50. PubMed ID: 16321840
[TBL] [Abstract][Full Text] [Related]
27. Successful Use of Adalimumab for Treating Pyoderma Gangrenosum with Ulcerative Colitis under Corticosteroid-tapering Conditions.
Sagami S; Ueno Y; Tanaka S; Nagai K; Hayashi R; Chayama K
Intern Med; 2015; 54(17):2167-72. PubMed ID: 26328641
[TBL] [Abstract][Full Text] [Related]
28. Subcorneal Pustular Dermatosis Occuring in Association with Pyoderma Gangrenosum and Rheumatoid Arthritis: A Triple Whammy!
Khurana A; Sachdeva S; Paliwal P; Gogate S
Indian Dermatol Online J; 2023; 14(6):861-863. PubMed ID: 38099012
[TBL] [Abstract][Full Text] [Related]
29. Pyoderma gangrenosum, acne, hidradenitis suppurativa syndrome associated with type 1 diabetes mellitus treated with adalimumab.
Fattore D; Pistone G; Bongiorno MR
G Ital Dermatol Venereol; 2019 Apr; 154(2):218-220. PubMed ID: 29368847
[No Abstract] [Full Text] [Related]
30. An update on adalimumab for pyoderma gangrenosum.
Yamamoto T
Drugs Today (Barc); 2021 Sep; 57(9):535-542. PubMed ID: 34586101
[TBL] [Abstract][Full Text] [Related]
31. Adalimumab plus topical tacrolimus for the treatment of pyoderma gangrenosum: Report of a case.
Marasca C; Fontanella G; Annunziata MC; Marasca D; Fabbrocini G
Int Wound J; 2019 Aug; 16(4):1047-1048. PubMed ID: 30938050
[No Abstract] [Full Text] [Related]
32. Development of pemphigus vegetans and exacerbation of pemphigus foliaceus after secukinumab loading in a patient with complicated generalized pustular psoriasis and pyoderma gangrenosum.
Minai L; Takeichi T; Ogawa Y; Honobe-Tabuchi A; Okamoto T; Mitsui H; Shimada S; Akiyama M; Kawamura T
J Dermatol; 2023 Feb; 50(2):245-249. PubMed ID: 36052669
[TBL] [Abstract][Full Text] [Related]
33. Adalimumab in Japanese patients with active ulcers of pyoderma gangrenosum: Twenty-six-week phase 3 open-label study.
Yamasaki K; Yamanaka K; Zhao Y; Iwano S; Takei K; Suzuki K; Yamamoto T
J Dermatol; 2020 Dec; 47(12):1383-1390. PubMed ID: 32804433
[TBL] [Abstract][Full Text] [Related]
34. Neutrophilic dermatoses as systemic diseases.
Prat L; Bouaziz JD; Wallach D; Vignon-Pennamen MD; Bagot M
Clin Dermatol; 2014; 32(3):376-88. PubMed ID: 24767185
[TBL] [Abstract][Full Text] [Related]
35. Successful Management of Anti-TNF-Induced Psoriasis Despite Continuation of Therapy in a Pyoderma Gangrenosum Patient.
Toussi A; Le ST; Barton VR; Ma C; Cheng MY; Sukhov A; Wilken R; Patel F; Wang E; Maverakis E
J Drugs Dermatol; 2020 Feb; 19(2):199-201. PubMed ID: 32129973
[TBL] [Abstract][Full Text] [Related]
36. Subcorneal Pustular Dermatosis Following SARS-CoV-2 Infection.
Iurillo A; Yumeen S; Imbriano D; Moad J; Kawaoka J; Grenier N; Wisco O
R I Med J (2013); 2023 Nov; 106(10):51-53. PubMed ID: 37890065
[TBL] [Abstract][Full Text] [Related]
37. Successful use of adalimumab to treat pyoderma gangrenosum, acne and suppurative hidradenitis (PASH syndrome) following colectomy in ulcerative colitis.
Murphy B; Morrison G; Podmore P
Int J Colorectal Dis; 2015 Aug; 30(8):1139-40. PubMed ID: 25564349
[No Abstract] [Full Text] [Related]
38. Pustular vasculitis and superficial bullous pyoderma gangrenosum in a patient with ulcerative colitis.
Lazarov A; Amichai B; Halevy S
Cutis; 1995 Nov; 56(5):297-300. PubMed ID: 8565618
[TBL] [Abstract][Full Text] [Related]
39. Pyoderma gangrenosum triggered by switching from adalimumab to secukinumab.
Jin K; Matsuzaki Y; Akasaka E; Nakano H; Sawamura D
J Dermatol; 2019 Mar; 46(3):e108-e109. PubMed ID: 30192400
[No Abstract] [Full Text] [Related]
40. Subcorneal pustular dermatosis (Sneddon-Wilkinson disease) with amicrobial lymph node suppuration and aseptic spleen abscesses.
Dallot A; Decazes JM; Drouault Y; Rybojad M; Verola O; Morel P; Modai J; Puissant A
Br J Dermatol; 1988 Dec; 119(6):803-7. PubMed ID: 3060195
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
